Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-24 12:04 PM View:  | Anaptysbio, Inc (ANAB) | 14-Aug-24 | Market Purchase | 273,972 | $36.50 | $9,999,980.00 | 4% 7.52M to 7.79M | (7%) |
| 21-Jun-23 4:04 PM View: | Zymeworks Inc. (ZYME) | 16-Jun-23 | Market Purchase | 3,350,000 | $8.12 | $27,202,000.00 | 33% 10.09M to 13.44M | (5%) |
| 30-Mar-23 5:47 PM View: | Zymeworks Inc. (ZYME) | 28-Mar-23 | Market Purchase | 200,000 | $8.00 | $1,600,000.00 | 2% 9.89M to 10.09M | (4%) |
| 23-Jan-23 6:00 PM View: | Zymeworks Inc. (ZYME) | 20-Jan-23 | Purchase | 163,400 | $9.88 | $1,615,090.00 | 2% 9.72M to 9.89M | |
| 23-Jan-23 6:00 PM View: | Zymeworks Inc. (ZYME) | 19-Jan-23 | Purchase | 144,100 | $9.49 | $1,367,640.00 | 2% 9.58M to 9.72M | |
| 18-Jan-23 6:27 PM View: | Zymeworks Inc. (ZYME) | 18-Jan-23 | Purchase | 203,000 | $10.00 | $2,029,050.00 | 2% 9.38M to 9.58M | |
| 18-Jan-23 6:27 PM View: | Zymeworks Inc. (ZYME) | 17-Jan-23 | Purchase | 440,000 | $9.80 | $4,313,850.00 | 5% 8.94M to 9.38M | |
| 18-Jan-23 6:27 PM View: | Zymeworks Inc. (ZYME) | 13-Jan-23 | Purchase | 342,100 | $9.81 | $3,354,630.00 | 4% 8.59M to 8.94M | |
| 11-Jan-23 6:26 PM View: | Voyager Therapeutics, Inc. (VYGR) | 11-Jan-23 | Sale | 110,000 | $8.50 | $934,615.00 | (3%) 3.96M to 3.85M | |
| 12-Jan-23 4:47 PM View: | Zymeworks Inc. (ZYME) | 11-Jan-23 | Market Purchase | 106,300 | $7.87 | $836,910.00 | 1% 8.49M to 8.59M | (2%) |
| 11-Jan-23 6:26 PM View: | Voyager Therapeutics, Inc. (VYGR) | 10-Jan-23 | Sale | 336,400 | $8.05 | $2,709,430.00 | (8%) 4.3M to 3.96M | |
| 12-Jan-23 4:47 PM View: | Zymeworks Inc. (ZYME) | 10-Jan-23 | Market Purchase | 920,000 | $7.65 | $7,037,170.00 | 12% 7.57M to 8.49M | < 1% |
| 11-Jan-23 6:26 PM View: | Voyager Therapeutics, Inc. (VYGR) | 09-Jan-23 | Private Sale | 456,000 | $7.67 | $3,498,300.00 | (10%) 4.75M to 4.3M | |
| 23-Jun-22 5:21 PM View: | Voyager Therapeutics, Inc. (VYGR) | 23-Jun-22 | Purchase | 376,000 | $5.66 | $2,126,540.00 | 9% 4.38M to 4.75M | |
| 23-Jun-22 5:21 PM View: | Voyager Therapeutics, Inc. (VYGR) | 21-Jun-22 | Purchase | 101,400 | $5.28 | $535,504.00 | 2% 4.28M to 4.38M | |
| 09-May-22 6:01 AM View: | Prothena Corporation plc (PRTA) | 05-May-22 | Purchase | 1,062,740 | $29.02 | $30,840,600.00 | 5% 23.17M to 24.23M | |
| 09-May-22 6:01 AM View: | Prothena Corporation plc (PRTA) | 05-May-22 | Sale | 1,062,740 | $29.02 | $30,840,600.00 | (4%) 24.23M to 23.17M | |
| 09-May-22 6:04 AM View: | Anaptysbio, Inc (ANAB) | 05-May-22 | Private Purchase | 668,237 | $21.63 | $14,454,000.00 | 4% 15.04M to 15.71M | |
| 09-May-22 6:04 AM View: | Anaptysbio, Inc (ANAB) | 05-May-22 | Sale | 668,237 | $21.63 | $14,454,000.00 | (4%) 15.71M to 15.04M | |
| 12-Jan-22 6:12 PM View: | Prothena Corporation plc (PRTA) | 12-Jan-22 | Purchase | 300,000 | $37.50 | $11,250,300.00 | 3% 11.28M to 11.58M | |
| 10-Dec-21 6:50 PM View: | Odonate Therapeutics, Inc. (ODT) | 10-Dec-21 | Market Sale | 5,545,000 | $1.65 | $9,147,420.00 | (100%) 5.54M to 0 | (6%) |
| 10-Dec-21 6:50 PM View: | Odonate Therapeutics, Inc. (ODT) | 09-Dec-21 | Market Sale | 156,669 | $1.82 | $284,981.00 | (3%) 5.7M to 5.54M | 4% |
| 10-Dec-21 6:50 PM View: | Odonate Therapeutics, Inc. (ODT) | 01-Dec-21 | Market Purchase | 185,941 | $1.66 | $308,662.00 | 3% 5.7M to 5.89M | 5% |
| 10-Dec-21 6:50 PM View: | Odonate Therapeutics, Inc. (ODT) | 01-Dec-21 | Market Sale | 185,941 | $1.66 | $308,662.00 | (3%) 5.89M to 5.7M | (5%) |
| 01-Oct-21 7:39 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 01-Oct-21 | Market Sale | 2,000,000 | $4.96 | $9,928,800.00 | (96%) 2.08M to 81.08K | 3% |
| 01-Oct-21 7:39 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 30-Sep-21 | Market Sale | 3,000,000 | $5.04 | $15,131,100.00 | (59%) 5.08M to 2.08M | 4% |
| 22-Jun-21 5:05 PM View: | Prothena Corporation plc (PRTA) | 18-Jun-21 | Exercise (in-the money or at-the-money) | 250,000 | $30.00 | $7,500,000.00 | 2% 11.03M to 11.28M | |
| 04-May-21 4:51 PM View: | Anaptysbio, Inc (ANAB) | 04-May-21 | Market Purchase | 165,000 | $23.25 | $3,835,760.00 | 2% 7.36M to 7.52M | 2% |
| 04-May-21 4:51 PM View: | Anaptysbio, Inc (ANAB) | 03-May-21 | Market Purchase | 20,800 | $23.31 | $484,873.00 | < 1% 7.33M to 7.36M | 2% |
| 04-May-21 4:51 PM View: | Anaptysbio, Inc (ANAB) | 30-Apr-21 | Market Purchase | 35,700 | $23.16 | $826,816.00 | < 1% 7.3M to 7.33M | 2% |
| 27-Apr-21 6:23 PM View: | Anaptysbio, Inc (ANAB) | 27-Apr-21 | Market Purchase | 33,800 | $23.82 | $805,089.00 | < 1% 7.27M to 7.3M | 1% |
| 27-Apr-21 6:23 PM View: | Anaptysbio, Inc (ANAB) | 26-Apr-21 | Market Purchase | 13,900 | $23.80 | $330,859.00 | < 1% 7.25M to 7.27M | 1% |
| 27-Apr-21 6:23 PM View: | Anaptysbio, Inc (ANAB) | 23-Apr-21 | Market Purchase | 99,600 | $23.54 | $2,344,290.00 | 1% 7.15M to 7.25M | 2% |
| 25-Mar-21 11:14 AM View: | Prothena Corporation plc (PRTA) | 24-Mar-21 | Purchase | 875,000 | $20.75 | $18,156,200.00 | 9% 10.16M to 11.03M | |
| 10-Mar-21 5:53 PM View: | Anaptysbio, Inc (ANAB) | 09-Mar-21 | Market Purchase | 531,000 | $18.70 | $9,928,420.00 | 8% 6.62M to 7.15M | 2% |
| 10-Mar-21 5:53 PM View: | Anaptysbio, Inc (ANAB) | 08-Mar-21 | Market Purchase | 2,777,800 | $18.97 | $52,694,300.00 | 72% 3.84M to 6.62M | < 1% |
| 25-Feb-21 6:00 PM View: | Prothena Corporation plc (PRTA) | 24-Feb-21 | Purchase | 10,800 | $22.02 | $237,867.00 | < 1% 10.15M to 10.16M | |
| 25-Feb-21 6:00 PM View: | Prothena Corporation plc (PRTA) | 23-Feb-21 | Purchase | 44,400 | $21.05 | $934,518.00 | < 1% 10.1M to 10.15M | |
| 25-Feb-21 5:58 PM View: | Anaptysbio, Inc (ANAB) | 23-Feb-21 | Market Purchase | 29,500 | $25.48 | $751,657.00 | < 1% 3.81M to 3.84M | |
| 22-Feb-21 4:24 PM View: | Prothena Corporation plc (PRTA) | 18-Feb-21 | Private Purchase | 44,100 | $3.68 | $162,103.00 | < 1% 10.06M to 10.1M | |
| 17-Feb-21 7:14 PM View: | Prothena Corporation plc (PRTA) | 17-Feb-21 | Purchase | 198,840 | $23.46 | $4,665,540.00 | 2% 9.86M to 10.06M | |
| 17-Feb-21 7:14 PM View: | Prothena Corporation plc (PRTA) | 16-Feb-21 | Purchase | 89,200 | $22.78 | $2,031,970.00 | < 1% 9.77M to 9.86M | |
| 17-Feb-21 7:14 PM View: | Prothena Corporation plc (PRTA) | 12-Feb-21 | Purchase | 345,300 | $20.16 | $6,959,760.00 | 4% 9.43M to 9.77M | |
| 03-Sep-20 4:17 PM View: | Surface Oncology, Inc. (SURF) | 01-Sep-20 | Market Sale | 332,780 | $7.14 | $2,376,680.00 | (7%) 5.03M to 4.7M | (35%) |
| 02-Jul-20 5:20 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Conversion | 799,984 | -- | -- | 100% 0 to 799.98K | |
| 02-Jul-20 5:20 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Purchase | 1,176,000 | $17.00 | $19,992,000.00 | 147% 799.98K to 1.98M | |
| 27-May-14 6:11 PM View: | GenVec Inc. (GNVC) | 27-May-14 | Market Purchase | 9,040 | $2.39 | $21,620.10 | < 1% 1.98M to 1.99M | (79%) |
| 27-May-14 6:11 PM View: | GenVec Inc. (GNVC) | 23-May-14 | Market Purchase | 4,600 | $2.19 | $10,095.20 | < 1% 1.97M to 1.98M | (77%) |
| 27-May-14 6:11 PM View: | GenVec Inc. (GNVC) | 22-May-14 | Market Purchase | 10,500 | $2.13 | $22,367.10 | < 1% 1.96M to 1.97M | (77%) |
| 28-Mar-14 7:11 PM View: | GenVec Inc. (GNVC) | 28-Mar-14 | Market Purchase | 47,515 | $2.73 | $129,849.00 | 2% 1.91M to 1.96M | (82%) |